Omics Marker
Data analytics and diagnostic consultancy for healthcare and life-sciences organizations
Highlights
- New on EvolcAdded 2026-11-05
About Omics Marker
Omics Marker provides data analytics and diagnostic consultancy, including statistical modelling and validation, predictive analytics, machine learning, data visualization and data consultancy. It focuses on inflammatory bowel, metabolic and cancer diseases and aims to support translational research and patient stratification.
The company works with organizations on data projects, applying analytics to healthcare diagnostics. It is registered in Birmingham, United Kingdom, and was founded in 2019.
Product: Provides statistical modelling, machine learning, predictive analytics and other data consultancy services for healthcare diagnostics and research.
Jobs at Omics Marker
More health & medtech companies
Omnes Healthcare
Primary and secondary NHS care services for patients and healthcare partners across EnglandNew on EvolcOmniamed Communications
Medical communications and clinical education campaigns for healthcare professionals and healthcare industry clientsNew on EvolcOmnicare Pharmacy
Community pharmacy group in Scotland filling NHS prescriptions and offering travel vaccines and private services for local patientsNew on EvolcOmnicell
Medication and medical supply automation, inventory software and services for hospital and community pharmaciesNew on EvolcOn Medical
Medico-legal reporting, rehabilitation, diagnostics and treatment services for clients and organizations across the UKNew on EvolcOne Pharmacy
NHS community pharmacy offering prescription delivery, pharmacy services and online shopping to patients across EnglandNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Hosting
- ApacheHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.
